US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

272.38

+3.421.27%

Post-market: 272.380.00000.00%19:39 EDT

Volume:66.21K

Turnover:18.03M

Market Cap:2.96B

PE:31.87

High:272.91

Open:270.25

Low:270.25

Close:268.96

52wk High:272.91

52wk Low:171.06

Shares:10.85M

Float Shares:10.85M

Volume Ratio:0.89

T/O Rate:0.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:2.23

PE(LYR):7.21

Loading ...

Overview Company News Filings

Press Release: Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026

Veracyte to Report Q2 Results, Host Conference Call

Is Corcept Therapeutics (CORT) Fully Valued On Its Russell Index Removal?

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)

NeoGenomics Launches First FDA-Approved Prostate Cancer Companion Diagnostic

Veracyte Inc : Morgan Stanley Raises Target Price to $47.00 from $37.00

THOMSON REUTERS

NeoGenomics launches FDA-approved PTEN IHC prostate Cancer ompanion diagnostic

Neogenomics Launches Fda-approved Pten Ihc Companion Diagnostic for Prostate Cancer

THOMSON REUTERS

Corcept Chief Development Officer William Guyer Disposes of USD 1.87 Million in Common Shares

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)

Alkermes - no Penalties or Further Obligations Owed by Alkermes or Amneal After Agreement Termination - SEC Filing

THOMSON REUTERS

Alkermes - Co and Amneal Terminate Authorized Generic Product Supply Agreement on July 6, 2026 - SEC Filing

THOMSON REUTERS

StemRIM Wins South Korean Patent for Gene Therapy Targeting Rare Skin Disorder

Press Release: Neogenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

Bruker Corp : Leerink Partners Raises Target Price to $70 from $60

THOMSON REUTERS

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $109,882.02

Corcept Endocrinology President Sean Maduck Sells USD 2.19 Million of Corcept Therapeutics Shares

Neogenomics on Track for Longest Winning Streak Since February 2019

Veracyte Inc : Jefferies Raises Target Price to $70 from $48

THOMSON REUTERS

Does Corcept’s Exit From Russell Defensive Indexes Reframe Its Risk Profile And Investor Base (CORT)?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/FBT/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":272.38,"timestamp":1787688000000,"preClose":268.96,"halted":0,"volume":66207,"hourTrading":{"tag":"盘后","latestPrice":272.38,"preClose":272.38,"latestTime":"19:39 EDT","volume":19,"amount":5175.64,"timestamp":1787701179823,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.012715645449137478,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Closed","change":3.42,"latestTime":"08-25 16:00:00 EDT","open":270.25,"high":272.91,"low":270.25,"amount":18033469.280700002,"amplitude":0.00989,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":268.96,"sharesOutstanding":11450002,"nav":269.14,"aum":2920169538.28,"bidAskSpread":0.00091,"preHourTrading":{"tag":"盘前","latestPrice":275.285,"preClose":268.96,"latestTime":"08:35 EDT","volume":3,"amount":813.20499,"timestamp":1787661324519,"change":6.325,"changeRate":0.023517,"amplitude":0.023517},"postHourTrading":{"tag":"盘后","latestPrice":272.38,"preClose":272.38,"latestTime":"19:39 EDT","volume":19,"amount":5175.64,"timestamp":1787701179823,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.887222,"impliedVol":0.2196,"impliedVolPercentile":0.6773},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":0.887222,"shares":10850002,"dividePrice":0,"high":272.91,"amplitude":0.00989,"preClose":268.96,"low":270.25,"week52Low":171.0601,"pbRate":"2.23","psRate":"1088.16","week52High":272.91,"institutionHeld":0,"latestPrice":272.38,"eps":8.545272,"divideRate":0,"volume":66207,"delay":0,"ttmEps":8.545272,"open":270.25,"prevYearClose":206.52,"prevWeekClose":270.9465,"prevMonthClose":245.06,"prevQuarterClose":247.89,"fiveDayClose":260.7392,"twentyDayClose":251.3142,"sixtyDayClose":222.755},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650972435","title":"Press Release: Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2650972435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650972435?lang=en_us&edition=fundamental","pubTime":"2026-07-10 05:10","pubTimestamp":1783631400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--July 09, 2026--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the second ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4022","BK4139","BK4588","BK4585","FBT","VCYT","BK4555","TM","R","BK4232","BK4099","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974538","title":"Veracyte to Report Q2 Results, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974538","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974538?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:05","pubTimestamp":1783627519,"startTime":"0","endTime":"0","summary":"Veracyte to report Q2 results, host conference callVeracyte schedules release of second-quarter 2026 financial results for July 30, 2026.Management to host a conference call, webcast on July 30, 2026 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL9vhjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","FBT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650976961","title":"Is Corcept Therapeutics (CORT) Fully Valued On Its Russell Index Removal?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650976961","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650976961?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:32","pubTimestamp":1783614761,"startTime":"0","endTime":"0","summary":"What Corcept’s Index Removal Could Mean for Investors\nCorcept Therapeutics (CORT) was recently removed from the Russell 1000 Growth Defensive Index and the Russell 1000 Defensive Index, a shift that can influence trading activity as index funds rebalance positions.\nFor you as an investor, these index changes are less about Corcept Therapeutics business operations and more about how institutional owners that track these benchmarks may adjust their holdings. Such rebalancing can affect short...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/is-corcept-therapeutics-cort-fully-valued-on-its-russell-ind","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/is-corcept-therapeutics-cort-fully-valued-on-its-russell-ind","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CORT","LU1559883803.SGD","PSCH","LU0566484027.USD","BK4532","BK4007","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292217","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650292217?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:10","pubTimestamp":1783602606,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Immunome (IMNM) with bullish sen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMNM","BK4137","LABU","XBI","PSCH","XLV","BK4585","BK4563","HCSG","BK4139","ALKS","PSIL","LU0029874061.USD","BK4588","IBRN","MEDX","LU0128526141.USD","FBT","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112561177","title":"NeoGenomics Launches First FDA-Approved Prostate Cancer Companion Diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=1112561177","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112561177?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:50","pubTimestamp":1783601450,"startTime":"0","endTime":"0","summary":"NeoGenomics (NASDAQ: NEO) has announced the launch of the PTEN IHC CDx assay, the first immunohistochemistry companion diagnostic for prostate adenocarcinoma patients to receive approval from the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0012050646.USD","BK4121","FBT","BK4196","LABU","BK4585","BK4588","NEO","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650592935","title":"Veracyte Inc : Morgan Stanley Raises Target Price to $47.00 from $37.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2650592935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650592935?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:32","pubTimestamp":1783596774,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nAZN4T6V3M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VCYT","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650926253","title":"NeoGenomics launches FDA-approved PTEN IHC prostate Cancer ompanion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2650926253","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650926253?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:10","pubTimestamp":1783595410,"startTime":"0","endTime":"0","summary":"NeoGenomics (NEO) announced the launch of PTEN IHC CDx, the first immunohistochemistry companion diagnostic test approved by the FDA for patients w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neogenomics-launches-fda-approved-pten-ihc-prostate-cancer-ompanion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neogenomics-launches-fda-approved-pten-ihc-prostate-cancer-ompanion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","LU0012050646.USD","BK4092","BK4121","BK4585","LABU","FBT","LU0106261612.USD","BK4588","NEO","BK4162","PTEN","IHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650591926","title":"Neogenomics Launches Fda-approved Pten Ihc Companion Diagnostic for Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2650591926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650591926?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:05","pubTimestamp":1783595106,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43B0XH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4121","LU0106261612.USD","NEO","LU0012050646.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650914871","title":"Corcept Chief Development Officer William Guyer Disposes of USD 1.87 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2650914871","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650914871?lang=en_us&edition=fundamental","pubTime":"2026-07-09 07:55","pubTimestamp":1783554932,"startTime":"0","endTime":"0","summary":"Corcept Chief Development Officer William Guyer disposes of USD 1.87 million in common sharesCorcept: Chief Development Officer William Guyer exercised options for 20,000 common shares at USD 21.65 on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL7XHH1p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Chief Development Officer William Guyer Disposes of USD 1.87 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1559883803.SGD","BK4007","CORT","FBT","PSCH","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650997530","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650997530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650997530?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:50","pubTimestamp":1783525804,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-evolus-eols-alkermes-alks-and-volitionrx-vnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-evolus-eols-alkermes-alks-and-volitionrx-vnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","LU0128526141.USD","EOLS","MEDX","IBRN","PSIL","BK4007","BK4139","VNRX","LABU","BK4137","BK4581","XLV","HCSG","LU0029874061.USD","PSCH","FBT","BK4585","XBI","BK4588","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649993013","title":"Alkermes - no Penalties or Further Obligations Owed by Alkermes or Amneal After Agreement Termination - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649993013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649993013?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:05","pubTimestamp":1783512335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN43A0A0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","MEDX","PSIL","PSCH","FBT","BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649017993","title":"Alkermes - Co and Amneal Terminate Authorized Generic Product Supply Agreement on July 6, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649017993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649017993?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:05","pubTimestamp":1783512335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN43A0A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","PSIL","IBRN","PSCH","FBT","BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649963787","title":"StemRIM Wins South Korean Patent for Gene Therapy Targeting Rare Skin Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2649963787","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649963787?lang=en_us&edition=fundamental","pubTime":"2026-07-08 14:54","pubTimestamp":1783493684,"startTime":"0","endTime":"0","summary":"StemRIM Inc. ( ($JP:4599) ) has shared an update. StemRIM Inc. has secured patent protection in South Korea for a stem cell gene therapy technology...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/stemrim-wins-south-korean-patent-for-gene-therapy-targeting-rare-skin-disorder?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/stemrim-wins-south-korean-patent-for-gene-therapy-targeting-rare-skin-disorder?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","SYNB","FBT","BK4585","GNOM","CNCR","IBBQ","USRD","LFSC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984850","title":"Press Release: Neogenomics to Report Second Quarter 2026 Financial Results on July 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984850","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984850?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:06","pubTimestamp":1783422360,"startTime":"0","endTime":"0","summary":"FORT MYERS, Fla.--(BUSINESS WIRE)--July 07, 2026--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will repo","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NEO","LU0012050646.USD","FBT","LU0106261612.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649989716","title":"Bruker Corp : Leerink Partners Raises Target Price to $70 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2649989716","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649989716?lang=en_us&edition=fundamental","pubTime":"2026-07-07 18:15","pubTimestamp":1783419305,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nFWN4390C3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU1815336091.USD","BRKR","TINY","FBT","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649671125","title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $109,882.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2649671125","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649671125?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:49","pubTimestamp":1783370958,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $109,882.02Alkermes EVP and chief legal officer David Joseph Gaffin sold 2,034 ordinary shares on July 6, 2026.Shares were sold at USD 54.0","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL5RNxXp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $109,882.02","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","IBRN","FBT","PSCH","MEDX","ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649711546","title":"Corcept Endocrinology President Sean Maduck Sells USD 2.19 Million of Corcept Therapeutics Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2649711546","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649711546?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:45","pubTimestamp":1783370708,"startTime":"0","endTime":"0","summary":"Corcept Endocrinology President Sean Maduck sells USD 2.19 million of Corcept Therapeutics sharesSean Maduck, President, Corcept Endocrinology at Corcept Therapeutics, reported option exercise and share sales dated July 1, 2026.Exercised stock options for 25,000 shares at USD 8.27.Sold 24,?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDLZG90m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Endocrinology President Sean Maduck Sells USD 2.19 Million of Corcept Therapeutics Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","PSCH","BK4007","LU1559883803.SGD","LU0566484027.USD","CORT","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649678366","title":"Neogenomics on Track for Longest Winning Streak Since February 2019","url":"https://stock-news.laohu8.com/highlight/detail?id=2649678366","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649678366?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:32","pubTimestamp":1783351920,"startTime":"0","endTime":"0","summary":"NeoGenomics, Inc.  is currently at $15.38, up $0.22 or 1.45%--Would be highest close since Jan. 8, 2025, when it closed at $18.61--On pace for largest percent increase since July 1, 2026, when it rose 2.6%--Currently up 11 consecutive days; up 48.17% over this period--Longest winning streak since Feb. 25, 2019, when it rose for 11 straight trading days--Best 11-day stretch since the 11 days ending July 27, 2009, when it rose 56.72%--Up 30.78% year-to-date--Down 91.21% from its all-time closing high of $175.00 on Dec. 3, 1999--Up 110.4% from 52 weeks ago , when it closed at $7.31--Would be a new 52-week closing high--Up 217.77% from its 52-week closing low of $4.84 on July 31, 2025--Traded as high as $15.56; highest intraday level since Jan. 15, 2025, when it hit $16.18--Up 2.64% at today's intraday highAll data as of 11:21:29 AM ETSource: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 06, 2026 11:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NEO","LU0012050646.USD","FBT","LU0106261612.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649620474","title":"Veracyte Inc : Jefferies Raises Target Price to $70 from $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2649620474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649620474?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:09","pubTimestamp":1783350544,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VCYT","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649613232","title":"Does Corcept’s Exit From Russell Defensive Indexes Reframe Its Risk Profile And Investor Base (CORT)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649613232","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649613232?lang=en_us&edition=fundamental","pubTime":"2026-07-05 19:30","pubTimestamp":1783251030,"startTime":"0","endTime":"0","summary":"In late June 2026, Corcept Therapeutics was removed from both the Russell 1000 Defensive Index and the Russell 1000 Growth-Defensive Index, ending its inclusion in these benchmark portfolios. \nThis index removal can influence how quantitatively driven and index-tracking investors view Corcept, potentially shifting demand for the stock as portfolios are rebalanced. \nNext, we’ll examine how Corcept’s removal from key Russell defensive indexes interacts with its existing investment narrative...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/does-corcepts-exit-from-russell-defensive-indexes-reframe-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/does-corcepts-exit-from-russell-defensive-indexes-reframe-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1559883803.SGD","BK4532","FBT","CORT","LU0566484027.USD","BK4007","PSCH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}